Validation of UAS7 among children with chronic spontaneous urticaria

J Allergy Clin Immunol Pract. 2022 Jul;10(7):1927-1929.e1. doi: 10.1016/j.jaip.2022.02.033. Epub 2022 Mar 8.
No abstract available

MeSH terms

  • Anti-Allergic Agents* / therapeutic use
  • Child
  • Chronic Disease
  • Chronic Urticaria*
  • Humans
  • Omalizumab / therapeutic use
  • Treatment Outcome
  • Urticaria* / diagnosis
  • Urticaria* / drug therapy

Substances

  • Anti-Allergic Agents
  • Omalizumab